Nadia Speaks...

Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs

31 min · 8 de jun de 2025
Portada del episodio Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs

Descripción

In this episode, Nadia sits down with her brother, renowned cancer surgeon Dr. Anton Bilchik, to delve into the future of weight loss, metabolism, and significant medical breakthroughs. This episode dives into why obesity, an epidemic and major risk factor for cancer and heart disease, is so difficult to manage through traditional means and how novel GLP-1 and dual agonist drugs are changing the landscape of sustainable weight loss. Dr. Bilchik also shares with us, the latest research into the broader implications of these medications, including their potential for cancer and cardiovascular disease prevention, while emphasizing the critical need for physician oversight and a holistic approach to their use.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Nadia Speaks...!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

23 episodios

Portada del episodio Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs

Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs

In this episode, Nadia sits down with her brother, renowned cancer surgeon Dr. Anton Bilchik, to delve into the future of weight loss, metabolism, and significant medical breakthroughs. This episode dives into why obesity, an epidemic and major risk factor for cancer and heart disease, is so difficult to manage through traditional means and how novel GLP-1 and dual agonist drugs are changing the landscape of sustainable weight loss. Dr. Bilchik also shares with us, the latest research into the broader implications of these medications, including their potential for cancer and cardiovascular disease prevention, while emphasizing the critical need for physician oversight and a holistic approach to their use.

8 de jun de 202531 min